2002
DOI: 10.1086/342734
|View full text |Cite
|
Sign up to set email alerts
|

Neuregulin 1 and Susceptibility to Schizophrenia

Abstract: The cause of schizophrenia is unknown, but it has a significant genetic component. Pharmacologic studies, studies of gene expression in man, and studies of mouse mutants suggest involvement of glutamate and dopamine neurotransmitter systems. However, so far, strong association has not been found between schizophrenia and variants of the genes encoding components of these systems. Here, we report the results of a genomewide scan of schizophrenia families in Iceland; these results support previous work, done in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

43
1,366
9
15

Year Published

2003
2003
2010
2010

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 1,524 publications
(1,443 citation statements)
references
References 54 publications
43
1,366
9
15
Order By: Relevance
“…22 Finally, mouse models with disruptions in NRG1-ERBB4 signaling appear to capture some of the behavioral phenotypes associated with schizophrenia, and in certain cases these altered behaviors can be ameliorated by antipsychotics. 1,[23][24][25] Altogether, the data support a role for abnormal NRG1-ERB signaling in schizophrenia. Dissecting the pathways of NRG1-ERB signaling in the central nervous system may therefore contribute to the elucidation of pathways of schizophrenia susceptibility and may also reveal targets for interventions.…”
Section: Introductionsupporting
confidence: 55%
See 1 more Smart Citation
“…22 Finally, mouse models with disruptions in NRG1-ERBB4 signaling appear to capture some of the behavioral phenotypes associated with schizophrenia, and in certain cases these altered behaviors can be ameliorated by antipsychotics. 1,[23][24][25] Altogether, the data support a role for abnormal NRG1-ERB signaling in schizophrenia. Dissecting the pathways of NRG1-ERB signaling in the central nervous system may therefore contribute to the elucidation of pathways of schizophrenia susceptibility and may also reveal targets for interventions.…”
Section: Introductionsupporting
confidence: 55%
“…[1][2][3][4] NRG1 spans a 1.4-megabase region of chromosome 8p13, and is comprised of at least 20 exons. The gene undergoes complex alternative splicing, generating at least 15 protein isoforms that fall into six families (identified as I-VI).…”
Section: Introductionmentioning
confidence: 99%
“…9,[23][24][25][26][27][28][29]52 Two of the five SNPs defining the at-risk haplotype previously reported 9 were included in this study, SNPnrg2 and SNPnrg4. These two SNPs plus three additional ones typed in this study were located in the area of Hap ICE .…”
Section: Resultsmentioning
confidence: 99%
“…4,8 These factors along with possible genetic heterogeneity have complicated efforts to date aimed at elucidating the underlying genetic basis of this debilitating brain disorder. One of the most exciting candidate genes to come out of these studies in recent years is Neuregulin 1 (NRG1), which was first implicated in a genome wide scan in an Icelandic population by Stefansson et al 9 The chromosomal region where NRG1 is located, 8p12-p21, corresponds with an area previously identified as a schizophrenia susceptibility locus (SCZD6) by a number of earlier studies, although these failed to localise the gene involved. 8,[10][11][12] NRG1 is a very long 1.4 Mb gene with a large number of structurally and functionally distinct isoforms produced by alternative splicing.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation